Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

Subviral Agents

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...

Antifungal Agents

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...

Retroviruses

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Meeting report: 30th International Conference on Antiviral Research, in Atlanta, GA, USA.

Antiviral chemistry & chemotherapy·2018

Same author

Highlights of the 30th International Conference on Antiviral Research.

Antiviral research·2017

Same author

Meeting report: 29th International Conference on Antiviral Research in La Jolla, CA, USA.

Antiviral research·2016

Same author

Meeting report: 28th International Conference on Antiviral Research in Rome, Italy.

Antiviral research·2015

Same author

AVCC 1990-2015--A journal to combine antiviral biology and antiviral chemistry enters the third era.

Antiviral chemistry & chemotherapy·2015

Same author

Meeting report: 27th International conference on antiviral research, in Raleigh, NC, USA.

Antiviral research·2014

Search research articles

Related Experiment Video

Updated: May 9, 2026

Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals

Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals

Published on: September 20, 2021

Antiviral agents for herpes simplex virus.

R Anthony Vere Hodge¹, Hugh J Field

¹Vere Hodge Antivirals Ltd., Surrey, United Kingdom.

Advances in Pharmacology (San Diego, Calif.)

|July 27, 2013

Summary

Antiviral chemotherapy for herpes simplex virus (HSV) has advanced significantly, with acyclovir and famciclovir remaining mainstays. Emerging treatments show promise for resistant infections and future HSV research is active.

Keywords:

Antiviral chemotherapy CMX001 Famciclovir HSV Pritelivir Valacyclovir

More Related Videos

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Published on: May 13, 2021

A Primary Neuron Culture System for the Study of Herpes Simplex Virus Latency and Reactivation

A Primary Neuron Culture System for the Study of Herpes Simplex Virus Latency and Reactivation

Published on: April 2, 2012

Related Experiment Videos

Last Updated: May 9, 2026

Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals

Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals

Published on: September 20, 2021

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Published on: May 13, 2021

A Primary Neuron Culture System for the Study of Herpes Simplex Virus Latency and Reactivation

A Primary Neuron Culture System for the Study of Herpes Simplex Virus Latency and Reactivation

Published on: April 2, 2012

Area of Science:

Virology
Pharmacology
Infectious Diseases

Background:

Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) cause significant disease, necessitating effective antiviral chemotherapy.
Current therapies like acyclovir (ACV) and famciclovir (FCV) have been mainstays for two decades with a good safety profile.

Purpose of the Study:

To review the historical development and current status of antiviral therapies for HSV.
To explore novel compounds and future research directions for HSV treatment.
To discuss challenges in advancing new antiviral compounds.

Main Methods:

Literature review of preclinical studies and clinical trials for HSV antivirals.
Analysis of clinical experience with established and emerging HSV treatments.
Discussion of drug reclassification and research trends.

Main Results:

Acyclovir (ACV) and famciclovir (FCV) have been effective for two decades, with notable safety.
Newer agents like ME609, pritelivir, and CMX001 show potential for specific HSV infections.
Challenges exist in progressing novel compounds, but research is active.

Conclusions:

Established antivirals like ACV and FCV remain crucial for HSV management.
Novel approaches targeting viral enzymes and resistant strains are under investigation.
HSV research is moving beyond a quiescent phase with promising new avenues.